NEW YORK (GenomeWeb News) – Population Genetics said today that it has received funding to support a European-backed international research consortium studying genetic risk among children for relapse of acute lymphoblastic leukemia, or ALL.

Funded with €6 million ($7.5 million) from the European Commission, the five-year effort, called the IntReALL consortium, will engage 23 research teams seeking to develop a standardized treatment for this malignant childhood disease, an effort that will involve gathering, banking, and studying DNA from Europe, Japan, Israel, and Australia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.